Advanced search
Publication Cover
Expert Review of Vaccines Volume 13, 2014 - Issue 9: SPECIAL FOCUS: Pertussis, Part I. Guest Editor: Jan T Poolman
Submit an article Journal homepage
1,254
Views
1
CrossRef citations to date
0
Altmetric
Foreword

Pertussis vaccines

Jan T PoolmanCrucell Hollland B. V. one of the Janssen Pharmaceutical Companies of Johnson & Johnson – Bacterial Vaccines Research and Development Archimedesweg 4-6, Zernikedreef 9, Leiden 2333 CK, The NetherlandsCorrespondence[email protected]
Pages 1067-1069 | Published online: 12 Aug 2014

References

  • Guiso N. Pertussis vaccination and whooping cough: and now what? Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.941816. [Epub ahead of print]
  • Plotkin SA. Pertussis: pertussis control strategies and the options for improving current vaccines. Expert Rev Vaccines 2014;13(9):1071-2
  • Cherry JD. Adult pertussis in the pre and post vaccine eras: life long vaccine induced immunity? Expert Rev Vaccines 2014;13(9):1073-80
  • Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev Vaccines 2014;13(9):1115-23
  • Edwards KM. Review of the laboratory approaches to the detection of antibody and cell mediated immunity to pertussis disease and vaccine. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.946015
  • Geurtsen J, Fae KC, van den Dobbelsteen GPJM. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.944901. [Epub ahead of print]
  • Xing D, Markey K, Gaines DR, Feavers I. Whole cell pertussis vaccine (wP) potency assays: the Kendrick test and alternative assays. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.939636
  • Hegerle N, Guiso N. Bordetella pertussis and pertactin deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 2014;13(9):1135-46
  • Seubert A, D’Oro U, Scarselli M, Pizza M. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.942641
  • Guiso N, Hegerle N. Other Bordetellas, lessons for and from pertussis vaccines. Expert Rev Vaccines 2014;13(9):1125-33
  • Poolman JT. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.944902
  • Queenan AM, Fernandez J, Shang W, et al. The mouse intranasal challenge model for potency testing of whole cell pertussis vaccines. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.938642. [Epub ahead of print]
  • Gorringe AR, Vaughan TE. Bordetella pertussis fimbriae (Fim): relevance for vaccines. Expert Rev Vaccines 2014;13(10). doi:10.1586/14760584.2014.930667. [Epub ahead of print]
  • Sheridan SL, Frith K, Snelling TL, et al. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines 2014;13(9):1081-106
  • Locht C, Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev. Vaccines 2014;13(9):1147-58
  • Warfel JM, Merkel TJ. The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Rev. Vaccines 2014;13(10). doi:10.1586/14760584.2014.946016
  • Allen AC, Mills KHG. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity. Expert Rev. Vaccines 2014;13(10). doi:10.1586/14760584.2014.936391. [ Epub ahead of print]
  • Sebo P, Osicka R, Masin J. Adenylate cyclase toxin-hemolysin (CyaA) relevance for pertussis vaccines. Expert Rev. Vaccines 2014;13(10). doi:10.1586/14760584.2014.944900. [Epub ahead of print]
  • Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev. Vaccines 2014;13(9):1107-14
  • von König CHW. Pertussis diagnostics: overview and impact of immunization. Expert Rev. Vaccines 2014;13(10). doi:10.1586/14760584.2014.950237
  • Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. The Lancet 2014. doi:10.1016/S0140-6736(14)60686-3. [ Epub ahead of print]
  • DuMont AL, Yoong P, Liu X, et al. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect Immun 2014;82:1268-76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.